Cargando…
The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review
Anti-interleukin-17A (anti-IL-17A) therapy has been increasingly employed as a treatment option for pityriasis rubra pilaris (PRP). In this study, we reviewed all available studies on this topic in the literature to evaluate the efficacy and safety of anti-IL-17A. Our main objective was to assess th...
Autores principales: | Abduljawad, Mohammad, Alsharif, Thamer H, Gronfula, Amin G, Magadmi, Talah K, Khayat, Lujain I, Fageeh, Sarah M, Almuallim, Abdulqader A, Mohammad, Mohammad Ayman, Albadri, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382908/ https://www.ncbi.nlm.nih.gov/pubmed/37519579 http://dx.doi.org/10.7759/cureus.41125 |
Ejemplares similares
-
Misdiagnosed Pityriasis Rubra Pilaris Successfully Managed With Isotretinoin: A Case Series
por: Al Khalifa, Nayla, et al.
Publicado: (2023) -
Kaposi’s Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris
por: Guenther, Jana S, et al.
Publicado: (2023) -
Atypical Juvenile Pityriasis Rubra Pilaris: A Case Report of Early Onset With Late Diagnosis
por: Albrakati, Bakr A, et al.
Publicado: (2022) -
A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection
por: Duncan, Philicia, et al.
Publicado: (2023) -
Photosensitive pityriasis rubra pilaris
por: Męcińska-Jundziłł, Kaja, et al.
Publicado: (2016)